Document Detail

Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy.
MedLine Citation:
PMID:  22526618     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Choroidal neovascularization (CNV) is well recognized as a complication of laser photocoagulation for central serous chorioretinopathy (CSC). However, little is known about its management.
PATIENTS: Two patients who developed iatrogenic CNV after laser photocoagulation for CSC.
OBSERVATIONS: A single intravitreal bevacizumab (IVB) injection was given in both cases. The best-corrected visual acuity (BCVA) of 1 of the patients improved from 0.3 to 0.5 on the following day and to 1.2 three months after the IVB, and the BCVA of the other patient improved from 0.5 to 1.0 two weeks after the IVB. In both cases, the CNV became inactive 1 month after IVB on fluorescein angiography and remained stable for over 1 year.
CONCLUSION: IVB was beneficial for iatrogenic CNV that developed after laser photocoagulation for CSC.
Yoko Nomura; Ryo Obata; Yasuo Yanagi
Related Documents :
15225388 - Hand-assisted laparoscopic renal surgery in the morbidly and profoundly obese.
8855488 - Emptying of the intrathoracic stomach using three different pylorus drainage procedures...
512018 - The behavioral control of obesity: a descriptive analysis of a large-scale program.
11760078 - Effect of periodic endoscopy for gastric cancer on early detection and improvement of s...
22300068 - Adherence with migraine prophylaxis in clinical practice.
10532768 - Recombinant interferon alfa-2b in the treatment of vision-threatening capillary hemangi...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2012-04-20
Journal Detail:
Title:  Japanese journal of ophthalmology     Volume:  56     ISSN:  1613-2246     ISO Abbreviation:  Jpn. J. Ophthalmol.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-15     Completed Date:  2012-07-26     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  0044652     Medline TA:  Jpn J Ophthalmol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  245-9     Citation Subset:  IM    
Department of Ophthalmology, University of Tokyo School of Medicine, 7-3-1 Hongo, Tokyo, 113-8655, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiogenesis Inhibitors / administration & dosage*
Antibodies, Monoclonal, Humanized / administration & dosage*
Central Serous Chorioretinopathy / surgery*
Choroidal Neovascularization / drug therapy*,  etiology,  physiopathology
Fluorescein Angiography
Iatrogenic Disease*
Intravitreal Injections
Laser Coagulation / adverse effects*
Middle Aged
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Visual Acuity / physiology
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal, Humanized; 0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; 2S9ZZM9Q9V/bevacizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Detection of visual field defects in pre-perimetric glaucoma using fundus-oriented small-target peri...
Next Document:  The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colore...